Roche’s antitrust decision expected by end of year, Belgian official says
By Anna Ferrari ( May 19, 2026, 17:43 GMT | Insight) -- Belgian antitrust enforcers are set to issue a decision by the end of the year in their investigation into whether Roche Group hindered competition from biosimilar cancer treatments, Belgian competition prosecutor Anne-Charlotte Prévot said. An oral hearing before the authority’s board is scheduled after the summer, allowing the pharmaceutical company to respond to the allegations.Roche Group faces a decision from Belgian antitrust enforcers as soon as this year over allegations it hindered competition from biosimilar rivals to its cancer treatments, a senior official said Tuesday....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.